Creating a paradigm shift in the level of AI technology and its adoption and impact on society.
In collaboration with leading healthcare innovators & strategists, we are proving what’s possible in cancer surgery by accelerating innovation in surgical visualization.
Fluorescence Guided Surgery (FGS) has gained clinical and market acceptance as an effective tool to guide a surgical procedure.
Surgical Advisors
SHELDON
FELDMAN, MD
Professor of Surgery, Chief of Breast Surgery and Breast Surgical Oncology, Montefiore Medical Center
DAVID
WEINTRITT, MD
Clinical Assistant Professor of Surgery, George Washington University; Director of INOVA Mount Vernon Breast Care Institute; Founder, National Breast Center
PAUL
THIRUCHELVAM, MD, BSC, MBBS, FRCS, PhD
Consultant Breast and Reconstructive Surgeon, Department of Academic Breast Surgery, Imperial College
NIAMEY
WILSON, MD, FACS
Associate Director, Breast Program, Hartford HealthCare Cancer Institute Breast Surgery Division Leader Hartford HealthCare
Clinical Collaborators
MALINI HARIGOPAL, MD
Professor of Pathology; Director of Immunohistochemisry Lab, Yale School of Medicine
MINGHAO ZHONG, MD, Ph.D.
Associate Professor of Patholgy, Yale University School of Medicine
MARGARET ASSAAD, MD
Pathologist, Hartford HealthCare
Scientific Advisors
DR. JOSE COSTA
Professor of Pathology and Medicine (Oncology), Yale University School of Medicine
PROF. ISHAN BARMAN
Associate Professor, Johns Hopkins University
MICHAEL FENN, Ph.D
Director Healthcare & Life Sciences, Harvard Innovation Labs
JOHN MOON, Ph.D
Brown University
HEATHER COUTURE, Ph.D.
Pixel Scientia Labs
ROBERT LEIBERMAN, Ph.D.
President Lumoptix, LLC
Join us in investing in the future of what’s possible for cancer care.
